Literature DB >> 24599132

Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies.

Yinghui Li1, Vinay Tergaonkar.   

Abstract

Telomerase plays a pivotal role in bypassing cellular senescence and maintaining telomere homeostasis, essential properties required for the sustenance and progression of cancer. However, recent investigations have uncovered extratelomeric properties of telomerase that are independent of its role in telomere extension. This review summarizes recent insights to the noncanonical functions of telomerase reverse transcriptase (TERT) catalytic subunit, in particular in cancer progression, and highlights two major signaling mechanisms involved in the cross-talk with TERT-the NF-κB and Wnt/β-catenin pathways. We propose a feed-forward regulatory loop mechanism underlying TERT activation in cancers in which TERT acts as a transcriptional modulator of oncogenic signaling pathways that sustain its own levels and control the induction of target genes critical for tumor cell survival and proliferation. Finally, we provide a new perspective on telomerase-targeted cancer therapies and suggest possible interventions targeting the nontelomeric roles of TERT. This therapeutic strategy can be used in the future targeting of other telomerase components that exhibit novel nontelomeric functions in cancer and other ailments. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24599132     DOI: 10.1158/0008-5472.CAN-13-3568

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  67 in total

1.  Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.

Authors:  Yasushi Totoki; Kenji Tatsuno; Kyle R Covington; Hiroki Ueda; Chad J Creighton; Mamoru Kato; Shingo Tsuji; Lawrence A Donehower; Betty L Slagle; Hiromi Nakamura; Shogo Yamamoto; Eve Shinbrot; Natsuko Hama; Megan Lehmkuhl; Fumie Hosoda; Yasuhito Arai; Kim Walker; Mahmoud Dahdouli; Kengo Gotoh; Genta Nagae; Marie-Claude Gingras; Donna M Muzny; Hidenori Ojima; Kazuaki Shimada; Yutaka Midorikawa; John A Goss; Ronald Cotton; Akimasa Hayashi; Junji Shibahara; Shumpei Ishikawa; Jacfranz Guiteau; Mariko Tanaka; Tomoko Urushidate; Shoko Ohashi; Naoko Okada; Harsha Doddapaneni; Min Wang; Yiming Zhu; Huyen Dinh; Takuji Okusaka; Norihiro Kokudo; Tomoo Kosuge; Tadatoshi Takayama; Masashi Fukayama; Richard A Gibbs; David A Wheeler; Hiroyuki Aburatani; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2014-11-02       Impact factor: 38.330

2.  Mechanisms of Evolutionary Innovation Point to Genetic Control Logic as the Key Difference Between Prokaryotes and Eukaryotes.

Authors:  William Bains; Dirk Schulze-Makuch
Journal:  J Mol Evol       Date:  2015-07-25       Impact factor: 2.395

3.  Saccharomyces cerevisiae as a model for the study of extranuclear functions of mammalian telomerase.

Authors:  Lucia Simonicova; Henrieta Dudekova; Jaroslav Ferenc; Katarina Prochazkova; Martina Nebohacova; Roman Dusinsky; Jozef Nosek; Lubomir Tomaska
Journal:  Curr Genet       Date:  2015-01-08       Impact factor: 3.886

4.  Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.

Authors:  Gregory W Peek; Trygve O Tollefsbol
Journal:  Exp Cell Res       Date:  2016-03-23       Impact factor: 3.905

5.  Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.

Authors:  Cheryl M Koh; Ekta Khattar; Shi Chi Leow; Chia Yi Liu; Julius Muller; Wei Xia Ang; Yinghui Li; Guido Franzoso; Shang Li; Ernesto Guccione; Vinay Tergaonkar
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

6.  Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression.

Authors:  Ekta Khattar; Pavanish Kumar; Chia Yi Liu; Semih Can Akıncılar; Anandhkumar Raju; Manikandan Lakshmanan; Julien Jean Pierre Maury; Yu Qiang; Shang Li; Ern Yu Tan; Kam M Hui; Ming Shi; Yuin Han Loh; Vinay Tergaonkar
Journal:  J Clin Invest       Date:  2016-09-19       Impact factor: 14.808

7.  Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells.

Authors:  Jeffrey J Rodvold; Kevin T Chiu; Nobuhiko Hiramatsu; Julia K Nussbacher; Valentina Galimberti; Navin R Mahadevan; Karl Willert; Jonathan H Lin; Maurizio Zanetti
Journal:  Sci Signal       Date:  2017-06-06       Impact factor: 8.192

8.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

9.  Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients.

Authors:  Caroline Laheurte; Jeanne Galaine; Laurent Beziaud; Magalie Dosset; Jerome Kerzerho; Claire Jacquemard; Béatrice Gaugler; Christophe Ferrand; Anne Dormoy; François Aubin; Pascale Jacoulet; Virginie Westeel; Christophe Borg; Eric Tartour; Yann Godet; Bernard Maillère; Olivier Adotévi
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

Review 10.  Telomerase reactivation in cancers: Mechanisms that govern transcriptional activation of the wild-type vs. mutant TERT promoters.

Authors:  Yinghui Li; Vinay Tergaonkar
Journal:  Transcription       Date:  2016-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.